Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Kimberly-Clark (NYSE:KMB) from Buy to Hold.

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Science Applications International ...

“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...

After a turbulent year, things should calm for payers with the advent of a business-friendly Trump administration — though challenges will persist. Here are experts’ biggest predictions for 2025.

TD Cowen downgraded Kimberly-Clark (KMB) to Hold from Buy with a $145 price target While the firm maintains conviction in the company’s path ...

As previously reported, TD Cowen upgraded Coca-Cola (KO) to Buy from Hold with an unchanged price target of $75. Coke continues to execute “at ...

AI researchers and data scientists. Nvidia announced Project DIGITS — a desktop AI supercomputer with the company’s latest ...

Rate hike expectations +30bps sequentially, though still below survey average. Biz growth & confidence stepped up ...

The surprise departure of Federal Reserve vice chair for supervision Michael Barr is focusing new attention on Michelle ...